跳至主要内容
临床试验/NL-OMON56940
NL-OMON56940
尚未招募
不适用

Quantitative MRI for Blood Brain Barrier integrity Assessment without Gadolinium Based Contrast Agents - MRI BBB Integrity assessment GBCA-Free

Erasmus MC, Universitair Medisch Centrum Rotterdam0 个研究点目标入组 230 人待定

概览

阶段
不适用
干预措施
未指定
疾病 / 适应症
未指定
发起方
Erasmus MC, Universitair Medisch Centrum Rotterdam
入组人数
230
状态
尚未招募
最后更新
去年

概览

简要总结

暂无简介。

注册库
who.int
开始日期
待定
结束日期
待定
最后更新
去年
研究类型
Observational non invasive

研究者

入排标准

入选标准

  • Age \=\> 18 year
  • Patients from these pathologies will be included:
  • \* Brain Tumors.
  • Rationale: Contrast MRI is instrumental in detecting brain tumors, as these
  • agents help to delineate tumor margins, show the vascular supply, and highlight
  • areas of neovascularity or breakdown of the normal blood\-brain barrier.
  • \* Infections.
  • Rationale: In cases of brain infections like abscesses, encephalitis, or
  • meningitis, contrast MRI can help in defining the extent of the infection and
  • differentiating it from other pathologies.

排除标准

  • Patients with other pathologies even those which contrast agent is usually
  • prescribed such as vascular malformations, aneurysms, congenital malformations
  • and other vascular anomalies are excluded.
  • A patient who meets any of the following criteria will be excluded from
  • participation in this study:
  • \* Subjects with a typical contra\-indication to an MRI exam.
  • \* Subjects with metal implants.
  • \* Subjects who have a documented allergy to MRI contrast media or a
  • contra\-indication for contrast\-media or will not undergo contrast\-enhanced MRI.
  • \* Woman who are pregnant or lactating

结局指标

主要结局

未指定

相似试验